Bond Merck & CIE 1.7% ( US58933YBC84 ) in USD

Issuer	Merck & CIE
Market price	96.121 % ▲
Country	United States
ISIN code	US58933YBC84 ( in USD )
Interest rate	1.7% per year ( payment 2 times a year)
Maturity	10/06/2027
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	1 500 000 000 USD
Cusip	58933YBC8
Standard & Poor's ( S&P ) rating	A+ ( Upper medium grade - Investment-grade )
Moody's rating	Aa3 ( High grade - Investment-grade )
Next Coupon	10/12/2025 ( In 83 days )
Detailed description	Merck & Co., Inc. is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of innovative health solutions, including medicines, vaccines, and animal health products. This financial article details a specific bond issuance by Merck & Co., a global pharmaceutical giant renowned for its extensive research and development in medicines and vaccines, focusing on areas such as oncology, infectious diseases, and animal health, headquartered in the United States. Identified by ISIN US58933YBC84 and CUSIP 58933YBC8, this particular bond, denominated in USD, represents a substantial issuance with a total size of $1,500,000,000. It features an annual coupon rate of 1.7% with semi-annual payments, maturing on June 10, 2027. Investors considering this instrument should note its current market price of 95.368% of par value, indicating a discount, and the minimum purchase size set at $2,000. The bond boasts strong investment-grade credit ratings from leading agencies, specifically an A+ from Standard & Poor's and an Aa3 from Moody's, reflecting the issuer's robust financial health and low credit risk.